🔎 Trials Near Me

Home › Blood Cancers › NCT06469307

Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE)

RecruitingHealthy volunteers welcome

Who can join

Ages 18 and older · All sexes · Healthy volunteers welcome

Full eligibility criteria
CAB Participant Inclusion Criteria:

* Age 18 or older
* English speaking
* Ability to understand and willingness to provide oral consent
* DFCI patient who are in remission from a blood cancer \>1 year will be preferred.

CAB Participant Exclusion Criteria:

* Adults unable to consent
* Individuals who are not yet adults (infants, children, teenagers \<18 years old)
* Prisoners.
* Unwilling/unable to agree to maintaining the confidentiality of reviews and clinical trial materials, as outlined in Section 9.1
* Note 1: Patients and non-patient community members who are pregnant are eligible. This is a non-interventional study that meets the definition of minimal risk and poses no greater risk to pregnant individuals or fetuses. Pregnancy status will not be assessed.
* Note 2: English fluency is necessary as protocols being reviewed are written in English and cannot be feasibly translated to other languages within the time period necessary to complete timely reviews.

Investigator Participant Inclusion Criteria:

* Age 18 older
* English Speaking
* Site or Principal investigator
* Not a member of the research team

About the study

The purpose of this research study is to enhance inclusion and diversity in clinical trial enrollment by training participants to perform and provide feedback through a community-based protocol review process, called DIVERSE.

What is being tested

Sponsor: Dana-Farber Cancer Institute · Participants: 40 · Started: Dec 9, 2024

Contact the study team

Official record on ClinicalTrials.gov — NCT06469307

Locations in the U.S.

MassachusettsDana-Farber Cancer Institute, Boston

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.